Pediatric Drug Development: From Therapeutic Orphans to Evidence-Based Prescribing and How You Can Contribute To The Future

Dates and Times

Start: 1/14/2026 8:00 AM
End: 1/14/2026 9:00 AM

Objectives

• Summarize key historical milestones in pediatric drug development and their impact on current clinical practice.
• Describe how developmental physiology influences drug pharmacokinetics, pharmacodynamics, and dosing in pediatric patients.
• Interpret pediatric drug labeling with an understanding of how pediatric clinical trial data are generated and extrapolated.
• Recognize limitations in pediatric drug evidence and apply risk–benefit principles to prescribing decisions.
• Identify opportunities for clinicians to contribute to the future of pediatric drug development and research.

Speakers

Accreditation

The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits ^™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.